J Natl Compr Canc Netw. 2021 Nov;19(Suppl_1):S12-S15. doi: 10.6004/jnccn.2021.7094.
Every patient with cancer deserves access to evidence-based tobacco cessation interventions as part of their routine oncology care. The NCI Cancer Moonshot funded the Cancer Center Cessation Initiative (C3I) to help establish and/or expand tobacco treatment programs at 52 NCI-designated Cancer Centers. Although this initiative has broadened the availability of tobacco treatment services across US cancer centers, the reach and utilization of these services remains low among patients. To help address the remaining gap between the availability and utilization of evidence-based treatments for tobacco use in the oncologic context, staff and investigators at C3I sites and the C3I Coordinating Center formed the C3I Implementation Science Working Group. The mission of this working group is to bring together clinicians, scientists, and policymakers who share a common interest in implementation science and treating tobacco use in the oncologic context to collaborate on projects aimed at shrinking the practice gap in this area. Through case study examples, we describe how the C3I Implementation Science Working Group is supporting efforts to identify effective ways to increase the utilization of evidence-based tobacco treatments within cancer treatment settings and promote the broader impact and long-term sustainability of C3I.
每位癌症患者都应获得基于证据的戒烟干预措施,作为其常规肿瘤学治疗的一部分。NCI 癌症登月计划资助了癌症中心戒烟倡议(C3I),以帮助在 52 个 NCI 指定的癌症中心建立和/或扩大烟草治疗项目。尽管这一倡议扩大了美国癌症中心烟草治疗服务的可及性,但这些服务在患者中的利用率仍然很低。为了帮助解决肿瘤学环境中基于证据的烟草使用治疗的可及性和利用率之间仍然存在的差距,C3I 站点的工作人员和研究人员以及 C3I 协调中心成立了 C3I 实施科学工作组。该工作组的任务是汇集对实施科学和在肿瘤学环境中治疗烟草使用有共同兴趣的临床医生、科学家和政策制定者,合作开展旨在缩小该领域实践差距的项目。通过案例研究示例,我们描述了 C3I 实施科学工作组如何支持努力确定在癌症治疗环境中增加基于证据的烟草治疗方法的利用率并促进 C3I 的更广泛影响和长期可持续性的有效方法。